Alembic Pharmaceuticals Receives USFDA EIR for Karakhadi API-III Facility

19 May, 2025, Bengaluru: Alembic Pharmaceuticals Limited has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its API-III manufacturing facility located at Karakhadi, Gujarat.

The inspection was conducted from 17th March, 2025 to 21st March, 2025.

Check Also

Understanding Edgebands: Choosing the Right Solution for Every Furniture Application

processing technologies further enhance this visual continuity, making transitions between the decorative surface and the …